abstract-dark-graphic-banner--3
Tuesday March 17th  |  11:30 AM ET / 8:30 AM PT

Patient-centric commercialization in practice: 

Lessons from consumer-oriented and specialty Rx brands

Join the conversation.

In this panel, senior leaders in commercial analytics and marketing will explore how patient-centric commercialization plays out across two very different brand realities. Panelists will unpack what’s foundational versus what’s contextual, how success metrics diverge (and sometimes conflict), and where shared lessons emerge across the spectrum.

The discussion will focus on:
  • What are the “non-negotiable” foundations to patient-centric commercialization

  • How data, technology, and AI can support this execution

  • What organizational challenges to address and what are the success drivers in their experience

  • What actions leaders should prioritize over the next 12–24 months

Turning investments into real patient impact:
Lessons from consumer-oriented and specialty Rx brands

Patient centricity means very different things depending on the brand. For consumer-oriented products, it often shows up as reach, relevance, and sustained engagement at scale. For specialty and complex therapies, it’s about precision, access, and navigating a complex patient journey. Yet across both, teams are grappling with the same challenge: how to turn data, AI, and technology investments into real patient impact, without losing trust or cohesion along the way.

Turning investments into real patient impact: Lessons from consumer-oriented and specialty Rx brands

Patient centricity means very different things depending on the brand. For consumer-oriented products, it often shows up as reach, relevance, and sustained engagement at scale. For specialty and complex therapies, it’s about precision, access, and navigating a complex patient journey. Yet across both, teams are grappling with the same challenge: how to turn data, AI, and technology investments into real patient impact, without losing trust or cohesion along the way.

Speakers

Jessica Crosbie

Jessica Crosbie

VP, Global Insights & Analytics Oncology BU,
Takeda

Mahmood 2

Mahmood Hanif

Executive Director, Global Marketing Lilly Diabetes & Obesity,
Eli Lilly

Group 1822

Gunjan Aggarwal

Head - Data & Analytics,
Averitas Pharma

Sonam-Dubey

Sonam Dubey

Moderator
Partner, Practice lead, Patient solutions,
Beghou